GlassScriptPhysician profile
Oscar A Schwartz
NPI 1003807314
$2,599.53
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
See the full distribution for Sleep Medicine (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $176 · 2020: $100 · 2021: $320 · 2022: $506 · 2023: $1,361 · 2024: $136.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,039 · Travel and Lodging: $393 · Education: $64.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,039.14 |
| Travel and Lodging | $393.47 |
| Education | $64.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $982.71 | 2021-2024 | Inspire |
| Harmony Biosciences LLC | $733.32 | 2020-2024 | Wakix |
| Jazz Pharmaceuticals INC. | $410.45 | 2019-2023 | |
| Resmed Corp | $206.12 | 2019-2024 | |
| Axsome Therapeutics, INC. | $77.94 | 2023-2024 | Sunosi |
| Idorsia Pharmaceuticals US INC | $70.05 | 2022-2023 | Quviviq |
| Arbor Pharmaceuticals, INC. | $48.95 | 2019 | |
| Avadel Cns Pharmaceuticals, LLC | $36.07 | 2023-2024 | Lumryz |
| Fisher & Paykel Healthcare INC | $19.76 | 2023 | Fisher & Paykel Healthcare |
| Pfizer INC. | $14.16 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Oscar Schwartz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.